EDGAR Filing Documents for 0001683168-22-008044

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]

SEC Accession No. 0001683168-22-008044

Filing Date

2022-11-28

Accepted

2022-11-28 08:32:04

Documents

Document Format Files

Seq	Description	Document	Type	Size
1	AMENDMENT NO. 2 TO FORM S-1	cns_s1a2.htm	S-1/A	297665
2	OPINION	cns_ex0501.htm	EX-5.1	15290
3	GRAPHIC	a1.jpg	GRAPHIC	5026
4	GRAPHIC	a2.jpg	GRAPHIC	12892
5	GRAPHIC	a3.jpg	GRAPHIC	2832
	Complete submission text file	0001683168-22-008044.txt		342904

Mailing Address 2100 WEST LOOP SOUTH SUITE 900 HOUSTON TX 77027

Business Address 2100 WEST LOOP SOUTH SUITE 900 HOUSTON TX 77027 1-800-946-9185

CNS Pharmaceuticals, Inc. (Filer) CIK: 0001729427 (see all company filings)